Cargando…
A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
BACKGROUND: COVID-19 is an illness caused by severe acute respiratory syndrome coronavirus 2. Due to its rapid spread, in March 2020 the World Health Organization (WHO) declared pandemic. Since the outbreak of pandemic many governments, scientists, and institutions started to work on new vaccines an...
Autores principales: | Sezer, Abas, Halilović-Alihodžić, Mervisa, Vanwieren, Annissa Rachel, Smajkan, Adna, Karić, Amina, Djedović, Husein, Šutković, Jasmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127474/ https://www.ncbi.nlm.nih.gov/pubmed/35608704 http://dx.doi.org/10.1186/s43141-022-00353-0 |
Ejemplares similares
-
Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis
por: Bilajac, Esma, et al.
Publicado: (2022) -
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022) -
Antiviral Evaluation of Herbal Drugs
por: Mukherjee, Pulok K.
Publicado: (2019) -
Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020) -
Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)